BCL2L1 and acute lymphoblastic leukemia: Interestingly, our findings also indicated that in T-ALL cells treated with CX-4945, the protein level of MCL-1 decreases with increasing concentrations of CX-4945, while the levels of BCL-XL, BIM, and BAX remain relatively stable.